Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) (vol 20, pg 614, 1997)

被引：0
|
作者：
Pyorala, K
Pedersen, TR
Kjekshus, J
Faergeman, O
Olsson, AG
Thorgeirsson, G
机构：
来源：
DIABETES CARE | 1997年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1048 / 1048
页数：1
相关论文
共 38 条
  • [31] High density lipoprotein cholesterol, low high density lipoprotein cholesterol and major cardiovascular events among patients with coronary heart disease in the scandinavian simvastatin survival study
    Zhang, Q.
    Sazonov, V.
    Cui, Y.
    Maccubbi, D. L.
    Cook, T. J.
    Pedersen, T. R.
    EUROPEAN HEART JOURNAL, 2008, 29 : 345 - 345
  • [32] MANAGEMENT OF THE LONG-TERM INTERVENTION WITH PRAVASTATIN IN ISCHEMIC DISEASE (LIPID) STUDY AFTER THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    TONKIN, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (09): : C107 - C112
  • [33] The metabolic syndrome and risk of major coronary events in the Scandinavian simvastatin survival study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
    Girman, CJ
    Rhodes, T
    Mercuri, M
    Pyörälä, K
    Kjekshus, J
    Pedersen, TR
    Beere, PA
    Gotto, AM
    Clearfield, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02): : 136 - 141
  • [34] Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
    Ballantyne, CM
    Olsson, AG
    Cook, TJ
    Mercuri, MF
    Pedersen, TR
    Kjekshus, J
    CIRCULATION, 2001, 104 (25) : 3046 - 3051
  • [35] Cost effectiveness of LDL-C reduction in Medicare managed care CHD patients; Implications from the Scandinavian simvastatin survival study (4S)
    Schwartz, JS
    Boccuzzi, SJ
    Murray, JF
    Roehm, JB
    Cook, JR
    Glick, H
    Kinosian, B
    Pedersen, T
    Kjekshus, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7672 - 7672
  • [36] Cholesterol lowering drug therapy in the prevention of coronary heart disease in the population - Evidence from WOSCOPS and 4S applied to the British Family Heart Study
    Wood, DA
    Pyke, SDM
    Thompson, SG
    HEART, 1996, 75 (05) : 115 - 115
  • [37] Cholesterol lowering drug therapy in the prevention of coronary heart disease - Evidence from WOSCOPS and 4S applied to the British Family Heart Study in general practice.
    Wood, DA
    Pyke, SDM
    Thompson, SG
    CIRCULATION, 1996, 94 (08) : 2979 - 2979
  • [38] Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] Study)
    Tikkanen, Matti J.
    Holme, Ingar
    Cater, Nilo B.
    Szcrek, Michael
    Faergeman, Ole
    Katelein, John J. P.
    On, Anders G.
    Larsen, Mogens Lytken
    Linclahl, Christina
    Pedersen, Terle R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (05): : 577 - 582
1234